These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 24886477

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma.
    Yamashita H, Onishi H, Murakami N, Matsumoto Y, Matsuo Y, Nomiya T, Nakagawa K, Japanese Radiological Society multi-institutional SBRT study group (JRS-SBRTSG).
    J Radiat Res; 2015 May; 56(3):561-7. PubMed ID: 25691453
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma - Initial Experience From an Australian Liver Cancer Service.
    Liu HY, Lee Y, McLean K, Leggett D, Hodgkinson P, Fawcett J, Mott R, Stuart K, Pryor D.
    Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):e194-e202. PubMed ID: 32345457
    [Abstract] [Full Text] [Related]

  • 5. Local control by salvage stereotactic body radiotherapy for recurrent/residual hepatocellular carcinoma after other local therapies.
    Kibe Y, Takeda A, Tsurugai Y, Eriguchi T.
    Acta Oncol; 2020 Aug; 59(8):888-894. PubMed ID: 32216593
    [Abstract] [Full Text] [Related]

  • 6. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases.
    Fumagalli I, Bibault JE, Dewas S, Kramar A, Mirabel X, Prevost B, Lacornerie T, Jerraya H, Lartigau E.
    Radiat Oncol; 2012 Sep 27; 7():164. PubMed ID: 23014094
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma.
    Takeda A, Sanuki N, Eriguchi T, Kobayashi T, Iwabutchi S, Matsunaga K, Mizuno T, Yashiro K, Nisimura S, Kunieda E.
    J Gastroenterol Hepatol; 2014 Feb 27; 29(2):372-9. PubMed ID: 23927053
    [Abstract] [Full Text] [Related]

  • 10. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
    Huang WY, Jen YM, Lee MS, Chang LP, Chen CM, Ko KH, Lin KT, Lin JC, Chao HL, Lin CS, Su YF, Fan CY, Chang YW.
    Int J Radiat Oncol Biol Phys; 2012 Oct 01; 84(2):355-61. PubMed ID: 22342300
    [Abstract] [Full Text] [Related]

  • 11. Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease.
    Gerum S, Heinz C, Belka C, Walter F, Paprottka P, De Toni EN, Roeder F.
    Radiat Oncol; 2018 May 29; 13(1):100. PubMed ID: 29843752
    [Abstract] [Full Text] [Related]

  • 12. Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.
    Wahl DR, Stenmark MH, Tao Y, Pollom EL, Caoili EM, Lawrence TS, Schipper MJ, Feng M.
    J Clin Oncol; 2016 Feb 10; 34(5):452-9. PubMed ID: 26628466
    [Abstract] [Full Text] [Related]

  • 13. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients.
    Sanuki N, Takeda A, Oku Y, Mizuno T, Aoki Y, Eriguchi T, Iwabuchi S, Kunieda E.
    Acta Oncol; 2014 Mar 10; 53(3):399-404. PubMed ID: 23962244
    [Abstract] [Full Text] [Related]

  • 14. Stereotactic body radiation therapy for centrally located hepatocellular carcinoma: outcomes and toxicities.
    Lazarev S, Hardy-Abeloos C, Factor O, Rosenzweig K, Buckstein M.
    J Cancer Res Clin Oncol; 2018 Oct 10; 144(10):2077-2083. PubMed ID: 30088143
    [Abstract] [Full Text] [Related]

  • 15. Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma.
    Gkika E, Schultheiss M, Bettinger D, Maruschke L, Neeff HP, Schulenburg M, Adebahr S, Kirste S, Nestle U, Thimme R, Grosu AL, Brunner TB.
    Radiat Oncol; 2017 Jul 12; 12(1):116. PubMed ID: 28701219
    [Abstract] [Full Text] [Related]

  • 16. Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion.
    Mathew AS, Atenafu EG, Owen D, Maurino C, Brade A, Brierley J, Dinniwell R, Kim J, Cho C, Ringash J, Wong R, Cuneo K, Feng M, Lawrence TS, Dawson LA.
    Eur J Cancer; 2020 Jul 12; 134():41-51. PubMed ID: 32460180
    [Abstract] [Full Text] [Related]

  • 17. Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma.
    Yoon SM, Lim YS, Park MJ, Kim SY, Cho B, Shim JH, Kim KM, Lee HC, Chung YH, Lee YS, Lee SG, Lee YS, Park JH, Kim JH.
    PLoS One; 2013 Jul 12; 8(11):e79854. PubMed ID: 24255719
    [Abstract] [Full Text] [Related]

  • 18. Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer.
    Kwon JH, Bae SH, Kim JY, Choi BO, Jang HS, Jang JW, Choi JY, Yoon SK, Chung KW.
    BMC Cancer; 2010 Sep 03; 10():475. PubMed ID: 20813065
    [Abstract] [Full Text] [Related]

  • 19. The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases.
    Andratschke N, Alheid H, Allgäuer M, Becker G, Blanck O, Boda-Heggemann J, Brunner T, Duma M, Gerum S, Guckenberger M, Hildebrandt G, Klement RJ, Lewitzki V, Ostheimer C, Papachristofilou A, Petersen C, Schneider T, Semrau R, Wachter S, Habermehl D.
    BMC Cancer; 2018 Mar 13; 18(1):283. PubMed ID: 29534687
    [Abstract] [Full Text] [Related]

  • 20. High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma.
    Jang WI, Kim MS, Bae SH, Cho CK, Yoo HJ, Seo YS, Kang JK, Kim SY, Lee DH, Han CJ, Kim J, Park SC, Kim SB, Cho EH, Kim YH.
    Radiat Oncol; 2013 Oct 27; 8():250. PubMed ID: 24160944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.